A federal judge last week killed a proposed $6.3 billion merger between office supply giants Staples and Office Depot, in the latest high-profile deal to fall apart.
Today, Judge Emmet G. Sullivan released an opinion outlining his reasons for agreeing with the Federal Trade Commission and rejecting the merger. In his opinion, Sullivan concurred that the deal would have jacked up prices for big-business customers in a way that would have violated US antitrust law.
In seeking to keep the deal alive, Staples and Office Depot had argued that the FTC’s attempts to shield “mega companies” from big prices were misplaced. The office-supply companies argued the merger “indisputably will benefit all retail customers, and more than 99 percent of our business customers,” according to Sullivan’s opinion.
However, Sullivan wrote that B-to-B customers (businesses that transact with other businesses) are entitled to protection under antitrust law — even if they are only part of the customer base.
“Antitrust laws exist to protect competition, even for a targeted group that represents a relatively small part of an overall market,” Sullivan wrote. Later on, he suggested the mergers could hurt this targeted group by writing, “There is overwhelming evidence in this case that large B-to-B customers constitute a market that Defendants could target for price increases if they were allowed to merge.”
In his decision, Sullivan also took aim at the highly unusual strategy of Staples and Office Depot not to call witnesses in their own defense, as Reuters noted.
Full Content: Yahoo Finance
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Fires Head of Copyright Office, Throwing U.S. AI Policy Into Disarray
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
H-E-B Joins Antitrust Battle Against Teva Over MS Drug Monopoly
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece